Completed PHASE2 INTERVENTIONAL 5-arm NCT01836471

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy

Sponsor: Novartis Pharmaceuticals

Conditions Asthma

Interventions Fluticasone 100 mcg Fluticasone 250 mcg Placebo QAW039 QAW039

Updated 8 times since 2017 Last updated: Jan 30, 2017 Started: May 31, 2013 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Asthma and is currently completed. Novartis Pharmaceuticals leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

May 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — May 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novartis Pharmaceuticals

Data source: Novartis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arad, Romania , Barranquilla, Colombia , Berlin, Germany , Bialystok, Poland , Bogotá, Colombia , Bucharest, Romania , Bucheon-si, South Korea , Cape Town, South Africa , Charleston, United States , Charlotte, United States and 54 more locations